Cuadra, Emie Flor T.
HRN: 12-05-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/05/2023
AMPICILLIN 1GM (VIAL)
04/05/2023
04/12/2023
IVT
2gms
Q6H
PROM
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes